Austria orders recall of unapproved cancer drug

Austrian authorities have ordered a recall of a cancer medication that was put on the market without proper approval.

Melphalan is a commonly injected in a solution to treat certain bone marrow cancers. But government medical authorities said Wednesday that "Melphalan Koanaa"—which comes from India—was packaged in Austria by a local company and marketed without official approval.

Austria's food and drug agency said Wednesday that initial results from analyzing the medication suggest it is safe. It and the Health Ministry say they have filed a against the Austrian company.


Explore further

Novartis insists its flu vaccines are safe

© 2017 The Associated Press. All rights reserved.

Citation: Austria orders recall of unapproved cancer drug (2017, August 16) retrieved 26 March 2019 from https://medicalxpress.com/news/2017-08-austria-recall-unapproved-cancer-drug.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more